Table 2 of
Sodi, Mol Vis 2012; 18:2736-2748.
Table 2. Clinical details of the VMD patients included in the study (families H-S).
Family | Family Member | Sex | Age (years) | Onset (years) | BCVA OD | BCVA OS | Fundus OD | Fundus OS | Notes |
---|---|---|---|---|---|---|---|---|---|
H | I-1 | M | 63 | 53 | 0.4 | 0.8 | VR | PH | MultRE |
H | II-1 | M | 34 | // | 1.0 | 1.0 | Norm | Norm | |
H | II-2 | F | 27 | // | 1.0 | 1.0 | Norm | Norm | |
I | II-1 | M | 22 | 2 | 0.3 | 0.7 | FI | FI | |
I | I-1 | M | 60 | 30 | 0.8 | 1.0 | VL | VL | MultOU |
I | II-2 | F | 20 | // | 1.0 | 1.0 | Norm | Norm | |
J | III-1 | F | 15 | 5 | 0.4 | 0.8 | FI | FI | CNV; P |
J | II-2 | M | 46 | 6 | 0.5 | 0.5 | VR | VR | |
J | II-3 | M | 52 | 10 | 0.7 | 0.3 | FI | FI | |
J | I-1 | M | 82 | 50 | 0.8 | 0.1 | AT | AT | |
K | I-2 | F | 45 | 33 | 0.3 | 0.7 | FI | VR | CNV; P; A |
K | II-1 | M | 16 | 7 | 0.2 | 0.9 | FI | PH | CNV;P |
K | I-3 | F | 40 | // | 1.0 | 1.0 | Norm | Norm | |
K | II-2 | M | 21 | // | 0.6 | 0.6 | Norm | Norm | Cong Ny |
K | II-3 | F | 19 | // | 1.0 | 1.0 | Norm | Norm | |
L | II-1 | M | 45 | 15 | 0.4 | 0.6 | PH | VR | |
M | II-1 | F | 38 | 25 | 0.3 | 0.5 | VR | VR | |
N | III-1 | M | 35 | 25 | 1.0 | 0.9 | PH | VR | |
N | II-3 | M | 47 | 35 | 0.2 | 1.0 | AT | PH | |
O | II-1 | F | 48 | 35 | 0.1 | 0.1 | VR | VR | |
P | II-1 | F | 62 | 47 | 0.5 | 0.6 | VR | PH | |
Q | I-2 | F | 72 | 60 | 0.2 | 0.5 | AT | VL | |
Q | II-1 | F | 44 | // | 1.0 | 1.0 | Norm | Norm | |
R | II-1 | F | 41 | 37 | 0.6 | 0.9 | VR | VL | |
S | II-1 | M | 32 | 25 | 0.8 | 1.0 | AT | AT |